Bora Pharmaceuticals Co., Ltd. ("Bora", TWSE: 6472), a global leader in pharmaceutical manufacturing, and Corealis Pharma Inc ...

OSE Immunotherapeutics Unveils 2026–2028 Strategic Plan With Four Opportunities for Value Creation Completion of Tedopi’s phase 3 in Non-Small Cell Lung Cancer One or two new rare/specialty ...

Drug discovery is a high-risk, high-cost endeavor, with over 90% of candidates failing in clinical development. A significant proportion of these ...

The Nutraceutical Excipients Market was valued at USD 4.5 billion in 2024, reflecting strong expansion driven by the rising consumption ...

Viking Therapeutics advances oral and injectable VK2735 for obesity with strong cash, pipeline depth, and key 2026 catalysts.

The Trump administration released its much-anticipated National Security Strategy this week. CFR convened six of its experts ...

Rentschler Biopharma, a global CDMO, and Coriolis Pharma, a global contract research and development organization, have ...

Goldman Sachs Industrials and Materials Conference 2025 December 3, 2025 1:30 PM ESTCompany ParticipantsPierre Brondeau - CEO ...

CEO Qiming He details how Newsun’s China-rooted, globally deployed innovation model is redefining biosolutions and ...

BIOMIND LABS ACCELERATES FDA PATHWAY FOR 5-MEO-DMT CANDIDATE BMND08 AND GRANTS STOCK OPTIONS TORONTO, ON / ACCESS Newswire / December 3, 2025 /Biomind Labs Inc. ("Biomind" or the "Company") (CBOE:BMND ...